ISRCTN08839267
Completed
Not Applicable
Incidence and outcome of perioperative renal failure after moderate and severe surgery
niversity Hospital Brussels (Universitair Ziekenhuis Brussel [UZ Brussel]) (Belgium)0 sites0 target enrollmentJune 14, 2013
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversity Hospital Brussels (Universitair Ziekenhuis Brussel [UZ Brussel]) (Belgium)
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients \=18 years male/female, who have had in 2010/2011 a moderate to high risk surgery
Exclusion Criteria
- •1\. Absence of moderate or high risk surgery
- •2\. \< 18 years and kidney transplant recipients
- •3\. Surgery under local anesthesia
- •4\. Patients in which no serum creatinine determination pre\-and postoperative was done
- •5\. Patients who already have preoperative end\-stage renal disease (ESRD) according to the RIFLE criteria
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Preoperative renal function affects perioperative AKI and CKD in lower GI surgerygastrointestinal diseaseJPRN-UMIN000033608Department of Anesthesiology Kawasaki Municipal Tama Hospital500
Not yet recruiting
Not Applicable
A study to evaluate the occurrence of kidney damage after major surgeries of abdomen in childreHealth Condition 1: O- Medical and SurgicalHealth Condition 2: C00-D49- NeoplasmsCTRI/2022/01/039163Tata Memorial Hospital
Unknown
Not Applicable
Acute Renal Failure in the Surgical Intense Care Units - NTUH-SICU-ARF (NSARF) StudyAcute Renal FailureSepsisPostoperativeNCT00451373National Taiwan University Hospital300
Not yet recruiting
Not Applicable
Metabolic and renal outcomes in cardiac surgery patients receiving SGLT2 inhibitorsCardiac surgery associated acute kidney injuryNL-OMON26563Amsterdam UMC location AMC80
Recruiting
Phase 4
The perioperative renal and metabolic outcomes after sodium-glucose cotransporter-2 inhibitor in cardiac surgery - an open-label phase IV randomized controlled trialNL-OMON52118Academisch Medisch Centrum80